Phase
Condition
Constipation
Bowel Dysfunction
Fecal Incontinence
Treatment
Non-invasive Sacral Neuromodulation
Invasive Sacral Neuromodulation
Clinical Study ID
Ages 2-17 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
age between 2-17 years
informed consent
chronic constipation according to the ROME IV criteria for more than 3 months withor without encopresis/soiling despite underlying diseases such as slow-transitconstipation, rectal evacuation disorders or Hirschsprung's disease.
refractory to conventional treatment in an appropriate weight-adapted application (training for bowel movements, lifestyle changes, pelvic floor training,pharmacological options)
in cases of Hirschsprung's disease: diagnosis confirmed histologically by rectalbiopsies and in case of resection of an aganglionic segement: period between surgeryand SNM at least 1 year
in cases of anorectal malformation or mechanical obstruction: post-surgical status:period between surgery and SNM at least 1 year
Exclusion
Exclusion Criteria:
metabolic, inflammatory, and hormonal causes for chronic constipation
toxic megacolon or further emergencies, which must be treated surgically
sacral fractures or substantial differences in the sacral anatomy
inflammatory bowel disorders
rectal prolapse
neuronal malignancies under medical and radiation therapy
seizures
Study Design
Study Description
Connect with a study center
Friedrich-Alexander-Universität Erlangen-Nürnberg, Pediatric Surgery
Erlangen, Bavaria 91054
GermanySite Not Available
Friedrich-Alexander-Universität Erlangen-Nürnberg, Pediatric Surgery
Erlangen 2929567, Bavaria 2951839 91054
GermanySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.